Turkey won't buy Russian vaccine, health minister says
By Ali Kucukgocmen ANKARA (Reuters) - Turkey has ruled out buying the Russian coronavirus vaccine since its development lacked 'good practice', its health minister said as Ankara steps up efforts to inoculate 50 million citizens by spring. The Haberturk news website quoted Health Minister Fahrettin Koca on Wednesday as saying the Russian vaccine did not meet 'good laboratory practice' conditions. 'Russia was not able to fulfil this
By Ali Kucukgocmen
ANKARA (Reuters) - Turkey has ruled out buying the Russian coronavirus vaccine since its development lacked "good practice", its health minister said as Ankara steps up efforts to inoculate 50 million citizens by spring.
The Haberturk news website quoted Health Minister Fahrettin Koca on Wednesday as saying the Russian vaccine did not meet "good laboratory practice" conditions.
"Russia was not able to fulfil this. Therefore, it was not possible for the WHO (World Health Organization) and the world to purchase this vaccine," Koca said. "It is not possible for this vaccine to receive a licence from us either. Therefore, it is out of our area of interest."
He did not specify which Russian vaccine he was referring to, but Turkey has spoken of conducting Phase III trials for "Sputnik-V", the world's first registered coronavirus vaccine.
The Russia Direct Investment Fund, which backs the Sputnik vaccine's development and is responsible for its marketing abroad, declined to comment.
Russia was the first country to grant regulatory approval for a novel coronavirus vaccine, doing so before large-scale trials were complete - which stirred concern among scientists and doctors about the safety and efficacy of the shot.
Turkey, with a population of 83 million, has signed a contract to buy 50 million doses of COVID-19 vaccine from China's Sinovac Biotech Ltd, and expects to begin vaccinations this month, prioritising health workers.
New daily coronavirus infections and deaths on Tuesday hit the highest levels since the coronavirus was first detected in Turkey in March. With more than 33,000 cases, Turkey currently has the fourth highest daily rate globally.
Koca said Turkey needs more vaccines with the aim of inoculating 50 million people by the end of April, adding that it was working to bring forward the delivery of 25 million doses of vaccine from Pfizer and BioNTech.
"They will be able to give us 25 million doses by the end of 2021. We are trying to pull this forward. We want it before the summer. There is a fire going on. We need to extinguish it as soon as possible," he told Haberturk.
Koca also said Turkey would not pay for the Sinovac vaccine if it "did not like it".
"We put this in the contract when we gave our order...If our results are not effective enough, we have the right to return the vaccines and not pay even five cents."
Ankara has imposed full weekend lockdowns and weekday curfews to combat the sharp rise in deaths and infections. President Tayyip Erdogan has said citizens should be patient until the vaccines arrive.
(Additional reporting by Anton Zverev; Editing by Daren Butler, William Maclean and Mark Heinrich)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
By Andy Sullivan and David Shepardson WASHINGTON (Reuters) - Republicans in the U.S. Congress faced growing blowback on Monday from businesses that said they would cut off campaign contributions to those who voted last week to challenge President-elect Joe Biden's victory. The announcements by Dow Inc., AT&T Inc.
By Djaffar Al Katanty GOMA, Congo (Reuters) - A line of Congolese park rangers raised their guns in salute on Monday as the coffin bearing their colleague Burhani Abdou Surumwe, a 30-year-old father of four, was buried in the black volcanic soil of a Muslim cemetery outside Goma.
TORONTO/NEW YORK (Reuters) - The COVID-19 pandemic deepened inequities in accessing and benefiting from education but the future of learning could be a more equal one, participants told Reuters Next panels on Monday.